Ramaswami, R., Mercado-Matos, J., Lurain, K., Widell, A., Ekwede, I., Agwu, I., Namubiru, M., Odeny, T. A., Lu, C., Whitby, D., Yarchoan, R. (2025). A phase I/II study of abemaciclib, a CDK4/6 inhibitor, in participants with HIV-associated and HIV-negative Kaposi sarcoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11505